









Markets
/
Stocks
/
nasdaq-holx
/

Hologic Inc

HOLX

74.810USD

+0.110+0.15%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

16.69BMarket Cap

30.83P/E TTM



Hologic Inc

74.810

+0.110+0.15%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Hologic Inc

Currency: USD Updated: 2026-02-06

Key Insights

Hologic Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 54 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 75.15.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hologic Inc's Score

Industry at a Glance

Industry Ranking

54 / 205

Overall Ranking

155 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Hologic Inc Highlights

StrengthsRisks

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4.10B.

Fairly Valued

The company’s latest PE is 30.83, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 217.54M shares, decreasing 11.63% quarter-over-quarter.

Held by Ken Fisher

Star Investor Ken Fisher holds 7.03K shares of this stock.

Analyst Rating

Based on 18 analysts

Hold

Current Rating

75.154

Target Price

+0.61%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Hologic Inc is 8.34, ranking 48 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.05B, representing a year-over-year increase of 2.54%, while its net profit experienced a year-over-year increase of 10.90%.

Score

Industry at a Glance

Previous score

8.34

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.76

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.46

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.18

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.30

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Hologic Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Hologic Inc is 6.84, ranking 145 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 30.83, which is 35.74% below the recent high of 41.85 and 38.26% above the recent low of 19.03.

Score

Industry at a Glance

Previous score

6.84

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 54/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Hologic Inc is 6.00, ranking 172 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 76.00, with a high of 79.00 and a low of 70.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 18 analysts

Hold

Current Rating

75.154

Target Price

+0.61%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Hologic Inc

HOLX

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Hologic Inc is 5.30, ranking 180 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 75.28 and the support level at 74.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

5.15

Change

0.15

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.122

Neutral

RSI(14)

48.700

Neutral

STOCH(KDJ)(9,3,3)

26.459

Buy

ATR(14)

0.276

High Vlolatility

CCI(14)

-46.430

Neutral

Williams %R

63.953

Sell

TRIX(12,20)

0.000

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

74.694

Buy

MA10

74.887

Sell

MA20

74.952

Sell

MA50

74.880

Sell

MA100

72.845

Buy

MA200

68.149

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Hologic Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 97.44%, representing a quarter-over-quarter decrease of 2.98%. The largest institutional shareholder is The Vanguard, holding a total of 25.98M shares, representing 11.64% of shares outstanding, with 2.92% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

26.11M

-2.20%

T. Rowe Price Investment Management, Inc.

21.55M

-10.52%

BlackRock Institutional Trust Company, N.A.

12.44M

-3.99%

Manulife Investment Management (North America) Limited

10.45M

-5.19%

State Street Investment Management (US)

9.98M

-1.21%

Geode Capital Management, L.L.C.

5.90M

+1.18%

Victory Capital Management Inc.

5.47M

-0.52%

Invesco Advisers, Inc.

4.36M

+0.82%

Black Creek Investment Management, Inc.

3.74M

-7.06%

Citadel Advisors LLC

3.00M

-19.21%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Hologic Inc is 9.95, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.73. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.